Blue Sky Capital Consultants Group Inc. Has $3.91 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Blue Sky Capital Consultants Group Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,748 shares of the medical equipment provider’s stock after buying an additional 1,035 shares during the quarter. Intuitive Surgical makes up 1.7% of Blue Sky Capital Consultants Group Inc.’s holdings, making the stock its 19th biggest position. Blue Sky Capital Consultants Group Inc.’s holdings in Intuitive Surgical were worth $3,912,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Tobam raised its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth about $30,000. Riggs Asset Managment Co. Inc. increased its stake in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares during the last quarter. Finally, First Command Advisory Services Inc. raised its holdings in shares of Intuitive Surgical by 3,750.0% in the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 75 shares during the period. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.8%

Shares of NASDAQ ISRG opened at $561.98 on Monday. The firm has a market cap of $201.46 billion, a P/E ratio of 74.34, a price-to-earnings-growth ratio of 4.57 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business’s 50 day moving average is $561.47 and its 200-day moving average is $508.95.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.84 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Truist Financial lifted their target price on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Daiwa Capital Markets boosted their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Finally, HSBC raised their price target on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $611.08.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.